- Home
- ARWR vs CUBI Comparison
ARWR vs CUBI Comparison
Compare ARWR & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- CUBI
- Stock Information
- Founded
- ARWR 2003
- CUBI 1994
- Country
- ARWR United States
- CUBI United States
- Employees
- ARWR N/A
- CUBI N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- CUBI Major Banks
- Sector
- ARWR Health Care
- CUBI Finance
- Exchange
- ARWR Nasdaq
- CUBI Nasdaq
- Market Cap
- ARWR 1.8B
- CUBI 1.4B
- IPO Year
- ARWR 1993
- CUBI 2012
- Fundamental
- Price
- ARWR $13.07
- CUBI $51.47
- Analyst Decision
- ARWR Buy
- CUBI Buy
- Analyst Count
- ARWR 11
- CUBI 10
- Target Price
- ARWR $41.44
- CUBI $65.44
- AVG Volume (30 Days)
- ARWR 1.7M
- CUBI 293.2K
- Earning Date
- ARWR 05-12-2025
- CUBI 04-24-2025
- Dividend Yield
- ARWR N/A
- CUBI N/A
- EPS Growth
- ARWR N/A
- CUBI N/A
- EPS
- ARWR N/A
- CUBI 3.98
- Revenue
- ARWR $2,500,000.00
- CUBI $591,500,000.00
- Revenue This Year
- ARWR $4,380.43
- CUBI $15.09
- Revenue Next Year
- ARWR $64.24
- CUBI $9.29
- P/E Ratio
- ARWR N/A
- CUBI $12.85
- Revenue Growth
- ARWR N/A
- CUBI N/A
- 52 Week Low
- ARWR $9.57
- CUBI $40.75
- 52 Week High
- ARWR $30.41
- CUBI $68.49
- Technical
- Relative Strength Index (RSI)
- ARWR 53.31
- CUBI 58.88
- Support Level
- ARWR $12.44
- CUBI $49.81
- Resistance Level
- ARWR $14.97
- CUBI $52.26
- Average True Range (ATR)
- ARWR 0.71
- CUBI 1.59
- MACD
- ARWR 0.16
- CUBI 0.47
- Stochastic Oscillator
- ARWR 61.36
- CUBI 91.16
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About CUBI Customers Bancorp Inc
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.